Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Alabama at Birmingham
With
Children's Hospital Medical Center, Cincinnati
Nephrotoxic medication-induced acute kidney injury (NTM-AKI) is a relevant yet underdiagnosed morbidity in the neonatal intensive care unit (NICU).
Up to 87% of very low birth weight infants are exposed to at least one nephrotoxic medication (NTM). NTM-AKI is associated with poor short and long-term outcomes.
Presently, no treatments exist for AKI beyond supportive care.
Age
0–1
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
all NICU inpatients under 1 year of age; greater than 4 days of age that are
* Receiving 3 or more nephrotoxic medications on the same day OR
* Receiving 3 or more days of an intravenous aminoglycoside or vancomycin
You may not be if
Less than 4 days of age
* Currently being treated for a urinary tract infection
* Presence of an acute kidney injury prior to enrollment
Clareo Health | Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU
